Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients
- PMID: 16267411
- DOI: 10.1097/01.md.0000189089.45003.52
Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients
Abstract
Based on a prospective cohort study of 1056 patients with sickle cell anemia (Hb SS) initiated in 1959, we investigated the influence of calendar era, age, sex, and prior medical conditions on the subsequent development of irreversible organ damage and survival using the Cox regression model with time-dependent covariates adjusting for all prior occurrences. We studied 30 acute clinical events, and focused on 8 prototypic forms of irreversible organ damage. Childhood survival to age 20 years has improved from 79% for those born before 1975 to 89% for children born in or after 1975. Bone infarction was a significant risk factor for avascular necrosis (p = 0.01), and infantile dactylitis was a significant risk factor for stroke (p = 0.01). Prior hospitalized vaso-occlusive sickle crisis in adults was significantly associated with the increased rate of avascular necrosis (p < 0.001), leg ulcers (p < 0.001), sickle chronic lung disease (p < 0.001), renal failure (p < 0.005), and early death (p < 0.001). The diagnosis of clearly evident clinical conditions such as leg ulcer, osteonecrosis, and retinopathy predicted an increased likelihood of developing a more lethal form of organ damage and earlier death: 77% of patients with chronic lung disease, 75% of those with renal insufficiency, and 51% of those with stroke had a prior chronic condition. Of the 232 patients who died, 73% had 1 or more clinically recognized forms of irreversible organ damage. By the fifth decade, nearly one-half of the surviving patients (48%) had documented irreversible organ damage. End-stage renal disease (glomerulosclerosis), chronic pulmonary disease with pulmonary hypertension, retinopathy, and cerebral microinfarctions are manifestations of arterial and capillary microcirculation obstructive vasculopathy. The current study underscores the need for preventive therapy to ameliorate the progression of the sickle vasculopathy.
Similar articles
-
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.Ann Hematol. 2020 Sep;99(9):2073-2079. doi: 10.1007/s00277-020-04057-8. Epub 2020 May 6. Ann Hematol. 2020. PMID: 32377816 Free PMC article.
-
Sickle cell anemia and major organ failure.Hemoglobin. 1990;14(6):573-98. doi: 10.3109/03630269009046967. Hemoglobin. 1990. PMID: 2101835 Review.
-
Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.Blood Cells Mol Dis. 2020 Sep;84:102438. doi: 10.1016/j.bcmd.2020.102438. Epub 2020 Apr 23. Blood Cells Mol Dis. 2020. PMID: 32504882
-
Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.Medicine (Baltimore). 1988 Jan;67(1):66-76. Medicine (Baltimore). 1988. PMID: 3336282
-
The young child with sickle cell disease.Adv Nurse Pract. 1998 Jun;6(6):32-9. Adv Nurse Pract. 1998. PMID: 9708052 Review.
Cited by
-
Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.J Clin Med. 2022 Aug 16;11(16):4775. doi: 10.3390/jcm11164775. J Clin Med. 2022. PMID: 36013014 Free PMC article.
-
Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12-year single health system-based cohort analysis.EJHaem. 2021 Jan 4;2(1):94-98. doi: 10.1002/jha2.161. eCollection 2021 Feb. EJHaem. 2021. PMID: 35846078 Free PMC article. No abstract available.
-
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.Sci Rep. 2022 Jun 13;12(1):9762. doi: 10.1038/s41598-022-13751-8. Sci Rep. 2022. PMID: 35697769 Free PMC article.
-
Factors Affecting the Exercise Capacity in Pediatric Primary Hypertension.Front Pediatr. 2022 May 25;10:882223. doi: 10.3389/fped.2022.882223. eCollection 2022. Front Pediatr. 2022. PMID: 35692974 Free PMC article.
-
Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies.J Clin Med. 2022 May 31;11(11):3118. doi: 10.3390/jcm11113118. J Clin Med. 2022. PMID: 35683502 Free PMC article. Review.
References
-
- Acquaye JK, Omer A, Ganeshaguru K, Sejeny A, Hoffbrand AV. Non-benign sickle cell anaemia in Western Saudi Arabia. Br J Haematol. 1985;60:99-108.
-
- Adamkiewicz TV, Mehta PS, Boyer MW, Kedar A, Olson TA, Olson E, Chiang KY, Maurer D, Mogul MJ, Wingard JR, Yeager AM. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Trans. 2004;34:405-411.
-
- Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH, Rogers ZR, Vichinsky E, Elliott J, Facklam RR, O'Brien KL, Schwartz B, Van Beneden CA, Cannon MJ, Eckman JR, Keyserling H, Sullivan K, Wong WY, Wang WC. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003;143:438-444.
-
- Adams RJ. Stroke prevention and treatment in sickle cell disease. Arch Neurol. 2001;58:565-568.
-
- Anson JA, Koshy M, Ferguson L, Crowell RM. Subarachnoid hemorrhage in sickle-cell disease. J Neurosurg. 1991;75:552-558.
Publication types
MeSH terms
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
